Related Experiment Video
Updated: Jul 14, 2026
11:58
Linear Amplification Mediated PCR – Localization of Genetic Elements and Characterization of Unknown Flanking DNA
Published on: June 25, 2014
Insertional mutagenesis in gene therapy and stem cell biology
1Department of Experimental Hematology, Hannover Medical School, Hannover, Germany. baum.christopher@mh-hannover.de
Current Opinion in Hematology
|May 31, 2007
Summary
Gene vector insertion into hematopoietic cells can cause mutations, leading to leukemia. New research clarifies mechanisms, improving gene therapy safety and revealing insights into stem cell biology for hematology and oncology.
Area of Science:
- Hematology
- Oncology
- Regenerative Medicine
- Gene Therapy
- Stem Cell Biology
Background:
- Semirandom transgene insertion into hematopoietic cells via gene vectors can induce clonal competition, potentially leading to leukemia or sarcoma.
- This insertional mutagenesis has raised concerns regarding the safety of advanced hematopoietic cell therapies.
- Understanding these mechanisms is crucial for developing safer gene therapy strategies.
Purpose of the Study:
- To review novel studies on the mechanisms of insertional mutagenesis caused by gene vectors in hematopoietic cells.
- To highlight advancements in improving gene vector biosafety.
- To explore new insights into stem cell biology derived from these studies.
Main Methods:
- Analysis of recent preclinical and clinical studies.
- Examination of cell culture assays and animal models (including disease-specific and cancer-prone mouse models).
- Review of evolving databases that summarize vector insertion sites in hematopoietic clones.
Main Results:
- The insertion patterns of retroviral gene vectors are influenced by viral integrase properties and cellular cofactors.
- Vector features and systemic factors contribute to the induction of clonal imbalance.
- New tools are emerging to identify genes regulating clonal homeostasis through insertion site analysis.
Conclusions:
- Mechanistic studies of insertional mutagenesis will yield improved tools for advanced hematopoietic cell therapy.
- These studies offer valuable insights into gene networks governing cell fitness.
- Findings have significant implications for hematology, oncology, and regenerative medicine.
Related Concept Videos
01:16In-vitro Mutagenesis
To learn more about the function of a gene, researchers can observe what happens when the gene is inactivated or “knocked out,” by creating genetically engineered knockout animals. Knockout mice have been particularly useful as models for human diseases such as cancer, Parkinson’s disease, and diabetes.
00:59Gene Therapy
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be inserted. The...
01:16In vitro Mutagenesis
To learn more about the function of a gene, researchers can observe what happens when the gene is inactivated or “knocked out,” by creating genetically engineered knockout animals. Knockout mice have been particularly useful as models for human diseases such as cancer, Parkinson’s disease, and diabetes.
02:53Conservative Site-specific Recombination and Phase Variation
Because the DNA segments are cut and reorganized in a direction-specific manner, site-specific recombination has emerged as an efficient genetic engineering technique. Flippase and Cyclization recombinases or Flp and Cre, respectively, are two members of the tyrosine recombinase family derived from bacteriophages, that are used to mediate site-specific DNA insertions, deletions, and targeted expression of proteins in mammalian cell lines.
The recognition sites for Cre recombinase called LoxP...
The recognition sites for Cre recombinase called LoxP...